136 results
DEF 14C
MYMX
Mymetics Corp
27 Oct 23
Information statement
5:12pm
; none issued or outstanding
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive income
Revenues
Research and development … services
Sales other
Grants
Expenses
Research and development
General and administrative
Operating Loss
Interest expense
Other (income) expense
Loss
PRE 14C
MYMX
Mymetics Corp
13 Oct 23
Preliminary information
6:48pm
are a vaccine company and are focused on the research and development of next generation vaccines for infectious and life disabling diseases. Our core …
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive income
Revenues
Research and development services
Sales other
Grants